J. Reed
EVP, Innovative Medicine, R&D
Johnson & Johnson · JNJ
$12.2M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A filed March 11, 2026. Prior years are from that filing's three-year table.
Catalog as of September 15, 2026. Not a live market feed.
- Salary
- $1.2M
- Stock Awards
- $6.2M
- Option Awards
- $2.4M
- Incentives
- $1.8M
- Other
- $593K
Compensation History
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,220,308 | $6,160,665 | $12,214,062 |
| 2024 | $1,192,308 | $3,953,124 | $9,304,430 |
| 2023 | $840,385 | $11,699,934 | $20,647,350 |
Current Position
- Company
- Johnson & Johnson
- Title
- EVP, Innovative Medicine, R&D
- Ticker
- JNJ · NYSE
- Fiscal Year
- 2025
SEC Sources
Fiscal years below are columns from the latest DEF 14A Summary Compensation Table (filed March 11, 2026), not separate historical filings.
| Fiscal Year | Source |
|---|---|
| 2025 | View SEC filing |
| 2024 | View SEC filing |
| 2023 | View SEC filing |
Accession 0000200406-26-000063.